UA113061C2 - MEDICAL DELIVERY SYSTEM - Google Patents

MEDICAL DELIVERY SYSTEM

Info

Publication number
UA113061C2
UA113061C2 UAA201314576A UAA201314576A UA113061C2 UA 113061 C2 UA113061 C2 UA 113061C2 UA A201314576 A UAA201314576 A UA A201314576A UA A201314576 A UAA201314576 A UA A201314576A UA 113061 C2 UA113061 C2 UA 113061C2
Authority
UA
Ukraine
Prior art keywords
delivery system
drug delivery
medical delivery
shell
immediate
Prior art date
Application number
UAA201314576A
Other languages
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/NL2012/050336 external-priority patent/WO2012158030A2/en
Publication of UA113061C2 publication Critical patent/UA113061C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Винахід стосується регульованої у часі системи доставки лікарського засобу з негайним вивільненням для перорального введення першого активного інгредієнта пацієнту, який цього потребує; пристрою для доставки подвійного лікарського засобу, що включає таку регульовану у часі з негайним вивільненням систему доставки лікарського засобу, в якій перша оболонка системи доставки лікарського засобу оточена другою оболонкою, що включає другий активний інгредієнт.The invention relates to a time-regulated immediate-delivery drug delivery system for oral administration of the first active ingredient to a patient in need thereof; a dual drug delivery device comprising a time-regulated, immediate-release drug delivery system in which the first shell of the drug delivery system is surrounded by a second shell comprising the second active ingredient.

UAA201314576A 2011-05-13 2012-05-14 MEDICAL DELIVERY SYSTEM UA113061C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11166091 2011-05-13
PCT/NL2012/050336 WO2012158030A2 (en) 2011-05-13 2012-05-14 Drug delivery system

Publications (1)

Publication Number Publication Date
UA113061C2 true UA113061C2 (en) 2016-12-12

Family

ID=44863383

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201314576A UA113061C2 (en) 2011-05-13 2012-05-14 MEDICAL DELIVERY SYSTEM

Country Status (1)

Country Link
UA (1) UA113061C2 (en)

Similar Documents

Publication Publication Date Title
EA201200937A1 (en) SOLID MEDICINE FORM TICAGRELOR
EA201391689A1 (en) SYSTEM OF DELIVERY MEDICINE
MY174727A (en) Stable, protracted glp-1/glucagon receptor co-agonists for medical use
CO6460769A2 (en) NEW VIRAL REPLICATION INHIBITORS
EA201400591A1 (en) INHALER
IN2014DN10548A (en)
EA201491479A1 (en) DERIVATIVES OF LUPANOV TRITERPENOIDS AND THEIR PHARMACEUTICAL APPLICATIONS
CY1118327T1 (en) USE OF A BYU PRODUCTION IN TREATMENT OF ACUTE EXTREMES OF COLD TEMPERATURE
CY1118032T1 (en) PROCESSES FOR COMMERCIAL PREPARATION OF PHARMACEUTICAL ACTIVE AGENT
MX344846B (en) Combination of active loaded granules with additional actives.
EP4360621A3 (en) Formulations of bendamustine
MY165888A (en) Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
PH12014501408A1 (en) Immediate release multi unit pellet system
EA201590797A1 (en) PREPARATIONS WITH THE MODIFIED PROBE RELEASE
CR20140358A (en) DRUG ADMINISTRATION SYSTEM
EA201501164A1 (en) SOLID PHARMACEUTICAL MEDICINE FORM
CR20110704A (en) COMPOSITIONS OF FIXED DOSAGE SOLID PHARMACEUTICALS THAT INCLUDE IRBESARTAN AND AMYLODIPINE, ITS PREPARATION AND THERAPEUTIC APPLICATION
EA201490862A1 (en) OSMOTICALLY ACTIVE VAGINAL DELIVERY SYSTEM
EA201071209A1 (en) APPLICATION OF DRUNEDARON OR ITS PHARMACEUTICALLY ACCEPTABLE SALT FOR OBTAINING A MEDICINE TO REGULATE KALIUM IN THE BLOOD
MX364652B (en) Pharmaceutical formulation comprising ciclesonide.
BR112015010808A2 (en) ibuprofen sodium based drug tablet dihydrate
UA113061C2 (en) MEDICAL DELIVERY SYSTEM
EA201992463A1 (en) DRUG DELIVERY SYSTEM
EA201491477A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING FLUPIRTIN
CN302374465S (en) drug delivery system